Got a tip?:

Posts Tagged ‘Novartis’

Novartis to Buy Cancer Drug Company Endocyte for $2.1 Billion

Swiss pharmaceutical giant Novartis is making a big acquisition under its new chief executive, Vasant Narasimhan. The company announced that it would be buying U.S. cancer drug maker Endocyte Inc. for $2.1 billion, or $24 a share for the company, in cash. Endocyte, which specializes in so-called radiopharmaceuticals, is developing a new treatment for prostate…

Read More